Skip to content
10-Q

Quarterly Report

HypGen Inc

0001662252-18-000079

← back to feed
Filed
Jul 24, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Jul 20, 2018 135.8M sh
Capex Q3 2018 · Feb 28, 2018 −$1.94K
Operating Cash Flow Q3 2018 · Feb 28, 2018 −$345K
Operating Cash Flow restated Q3 2018 · Feb 28, 2017 −$82.67K
Stockholders Equity Q3 2018 · Feb 28, 2018 −$508.43K
Stockholders Equity Q3 2018 · May 31, 2017 −$192.91K
Current Liabilities Q3 2018 · Feb 28, 2018 $681.19K
Current Liabilities Q3 2018 · May 31, 2017 $215.08K
Total Liabilities Q3 2018 · Feb 28, 2018 $681.19K
Total Liabilities Q3 2018 · May 31, 2017 $215.08K
Current Assets Q3 2018 · Feb 28, 2018 $171.12K
Current Assets Q3 2018 · May 31, 2017 $22.17K
Total Assets Q3 2018 · Feb 28, 2018 $172.76K
Total Assets Q3 2018 · May 31, 2017 $22.17K
Sga Expense Q3 2018 · Feb 28, 2018 $11.72K
Sga Expense Q3 2018 · Feb 28, 2018 $317.1K
Sga Expense restated Q3 2018 · Feb 28, 2017 $103.92K
Sga Expense restated Q3 2018 · Feb 28, 2017 $123.31K
Rd Expense Q3 2018 · Feb 28, 2018 $0
Rd Expense Q3 2018 · Feb 28, 2017 $0
Net Income Q3 2018 · Feb 28, 2018 −$121.61K
Net Income Q3 2018 · Feb 28, 2018 −$659.09K
Net Income Q3 2018 · Feb 28, 2017 −$105.46K
Net Income Q3 2018 · Feb 28, 2017 −$106.19K
Operating Income Q3 2018 · Feb 28, 2018 −$88.82K
Operating Income Q3 2018 · Feb 28, 2018 −$589.29K
Operating Income Q3 2018 · Feb 28, 2017 −$103.92K
Operating Income Q3 2018 · Feb 28, 2017 −$123.31K